Comparative Effectiveness of Symbicort vs. Advair among COPD patients

Study identifier:000152

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A U.S. Retrospective Database Analysis Evaluating the Comparative Effectiveness of Budesonide/Formoterol (BFC) vs. Fluticasone/Salmeterol (FSC) Combination in Patients with COPD.

Medical condition

COPD

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

3000

Study type

Observational

Age

40 Years +

Date

Study Start Date: 01 Aug 2013

Primary Completion Date: 01 Mar 2014

Study Completion Date: 01 Mar 2014

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2016 by AstraZeneca

Collaborators

Healthcore, Inc

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
Symbicort BFC patients new to ICS/LABA therapies	-
Advair FSC patients new to ICS/LABA therapies.	-

Documents available

Redacted protocol
Download
CSR Synopsis
Download
Trial Results Summaries
Available here

Contacts

Contact

Setareh Williams

302-885-1239